The independent source for health policy research, polling, and news.
281 - 300 of 540 Results
An Indiana man's family sued a state-owned nursing home for alleged mistreatment. A U.S. Supreme Court decision in the case could determine the right of many Americans to sue government agencies.
Independent medical practices keep closing as doctors join behemoth hospital groups or leave the field. Research suggests that鈥檚 bad news for patients. Studies repeatedly conclude that consolidation in the health care industry is driving up costs while showing no clear evidence of improved care.
Private Medicare Advantage health plans are increasingly ending coverage for skilled nursing or rehab services before medical providers think patients are healthy enough to go home, doctors and patient advocates say.
Montana is one of the latest states seeking to increase oversight of nonprofit hospitals鈥 giving to ensure they justify their tax-exempt status.
Shortly after birth, babies are pricked in the heel so their blood can be tested for life-threatening conditions. States generally save leftover blood from those samples, and parents and privacy experts are concerned that information could be used without consent years later.
Dr. Rochelle Walensky, head of the Centers for Disease Control and Prevention, has tapped Mary Wakefield to help 鈥渞eset鈥 the agency after its public failures handling the covid pandemic. Those who know Wakefield say her high standards and problem-solving skills make her a good fit for the job.
Since the U.S. Supreme Court overturned Roe v. Wade in June, ER doctors say they 鈥 and their patients 鈥 are trapped between state anti-abortion laws and the federal law requiring that care be delivered in emergency situations. Women鈥檚 lives hang in the balance.
In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas鈥 primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Bram Sable-Smith, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 installment about a very expensive ambulance trip.
A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Public health officials say monkeypox is not as dangerous as covid and can be handled well with current treatments and if those at risk use caution. But the rollout of vaccines has been slow and led to angst among some at-risk people.
Noble Health swept into two small Missouri towns promising to save their hospitals. Instead, workers and vendors say it stopped paying bills and government inspectors found it put patients at risk. Within two years 鈥 after taking millions in federal covid relief and big administrative fees 鈥 it locked the doors.
Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but it鈥檚 hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Michelle Andrews, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.
Insurers say prior authorization requirements are intended to reduce wasteful and inappropriate health care spending. But they can baffle patients waiting for approval. And doctors say that insurers have yet to follow through on commitments to improve the process.
Many public health workers are unable to see how many doses of Pfizer鈥檚 antiviral treatment are shipped to their communities and cannot tell whether vulnerable residents are filling prescriptions as often as their wealthier neighbors.
Three years after a government site launched to connect Americans to treatment, finding addiction care is still a struggle.
Prosecutors say opioid-seeking patients drove hours to get their prescriptions filled in Celina, Tennessee, where pharmacies ignored signs of substance misuse and paid cash 鈥 or 鈥渕onkey bucks鈥 鈥 to keep customers coming back.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need 鈥 and it doesn鈥檛 have the money to buy more.
What a difference a year makes. The speech was delivered to a largely unmasked crowd of lawmakers, justices, and Cabinet members in the House chamber.
State Medicaid agencies for months have been preparing for the end of a federal mandate that has prevented states from removing people from the safety-net program during the pandemic.
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of 鈥淧DUFA鈥 also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer鈥檚 disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN鈥檚 Julie Rovner to discuss these issues and more.
漏 2026 KFF